Marvel Biosciences Corp.
MRVL.V
TSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -55.30% | 385.61% | -66.93% | 584.91% | -31.27% |
| Total Receivables | -20.11% | -85.22% | 86.02% | -29.24% | 2.68% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.34% | -20.55% | 40.38% | -14.75% | 24.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -51.66% | 106.44% | -34.82% | 139.23% | -7.74% |
|
|
|||||
| Total Current Assets | -51.66% | 106.44% | -34.82% | 139.23% | -7.74% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -51.66% | 106.44% | -34.82% | 139.23% | -7.74% |
|
|
|||||
| Total Accounts Payable | -7.40% | 5.83% | 7.59% | -16.44% | 25.02% |
| Total Accrued Expenses | 5.85% | -21.21% | 61.13% | 9.28% | 16.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.31% | -1.24% | 130.63% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -0.41% | -1.20% | 59.28% | 38.38% | 23.62% |
|
|
|||||
| Total Current Liabilities | -0.41% | -1.20% | 59.28% | 38.38% | 23.62% |
| Long-Term Debt | -- | -- | -- | -56.51% | -3.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.41% | -1.20% | 26.27% | -4.71% | 9.50% |
|
|
|||||
| Common Stock & APIC | 4.16% | 6.76% | 0.24% | 16.47% | -3.67% |
| Retained Earnings | -5.62% | -1.37% | -9.98% | -7.09% | -0.54% |
| Treasury Stock & Other | 6.44% | 1.20% | 20.94% | 13.92% | 1.68% |
| Total Common Equity | -9.17% | 9.98% | -36.72% | 13.60% | -10.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.17% | 9.98% | -36.72% | 13.60% | -10.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.17% | 9.98% | -36.72% | 13.60% | -10.78% |
|
|
|||||